Malignant Female Reproductive System Neoplasm

Malignant Female Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,253 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,463
Recruiting: 820
Ph III recruiting: 96
Growth YoY: +6.3%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (740)

clinicaltrialsPublishedShowing 1–50 of 93 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06952660	Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer	recruiting	Phase 4	100	PfizerINDUSTRY	2	Sep 25, 2026	clinicaltrials
NCT04145518	Mechanistic Characterization of Uterine Pain(MCUP)	completed	Phase 4	183	Endeavor HealthOTHER	1	Sep 23, 2026	clinicaltrials
NCT05237947